BRIEF published on 08/05/2025 at 09:58, 5 months 18 days ago SCHOTT Pharma Updates FY 2025 Revenue and EBITDA Guidance Financial Results Revenue Growth EBITDA Margin SCHOTT Pharma FY 2025 Guidance
BRIEF published on 08/05/2025 at 09:58, 5 months 18 days ago SCHOTT Pharma met à jour ses prévisions de chiffre d'affaires et d'EBITDA pour l'exercice 2025 Résultats Financiers SCHOTT Pharma Marge EBITDA Croissance Des Revenus Orientations Pour L'exercice 2025
BRIEF published on 08/05/2025 at 09:46, 5 months 18 days ago État du capital et des droits de vote de bioMérieux en juillet 2025 Droits De Vote Capital Social BioMérieux AMF Juillet 2025
BRIEF published on 08/05/2025 at 09:46, 5 months 18 days ago Status of bioMérieux's capital and voting rights in July 2025 Share Capital Voting Rights BioMérieux AMF July 2025
BRIEF published on 08/05/2025 at 09:35, 5 months 18 days ago PFISTERER Invests in High-Voltage Laboratory to Enter HVDC Market Energy Infrastructure PFISTERER High-voltage Laboratory HVDC Market Silicone Expertise
BRIEF published on 08/05/2025 at 09:35, 5 months 18 days ago PFISTERER investit dans un laboratoire haute tension pour entrer sur le marché du HVDC Infrastructures Énergétiques PFISTERER Laboratoire Haute Tension Marché HVDC Expertise En Silicone
BRIEF published on 08/05/2025 at 09:31, 5 months 18 days ago Courtois S.A. : Décomposition des Droits de Vote au 31 juillet 2025 Droits De Vote Capital Social Actions En Circulation Courtois S.A. Obligations Statutaires
BRIEF published on 08/05/2025 at 09:31, 5 months 18 days ago Courtois SA: Breakdown of Voting Rights as of July 31, 2025 Share Capital Voting Rights Courtois SA Shares Outstanding Statutory Obligations
BRIEF published on 08/05/2025 at 09:10, 5 months 18 days ago BioNxt Solutions Advances Patent Protection for MS Treatment Multiple Sclerosis Drug Delivery Technology Patent Protection BioNxt Solutions Sublingual Cladribine
BRIEF published on 08/05/2025 at 09:10, 5 months 18 days ago BioNxt Solutions renforce la protection des brevets pour le traitement de la sclérose en plaques Sclérose En Plaques Technologie D'administration De Médicaments Solutions BioNxt Cladribine Sublinguale Protection Par Brevet
Published on 01/23/2026 at 08:05, 2 hours 30 minutes ago Tocvan Announces Multiple Silver Zones In Debut Drill Results From The Gran Pilar Project North Block
Published on 01/23/2026 at 00:00, 10 hours 35 minutes ago LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules
Published on 01/22/2026 at 23:00, 11 hours 35 minutes ago FutureGen Industries Announces Private Placement
Published on 01/22/2026 at 23:00, 11 hours 35 minutes ago Green Bridge Metals Commences Diamond Drilling Program at the Titac Project, Minnesota, USA
Published on 01/23/2026 at 10:27, 7 minutes ago EQS-Adhoc: ZF Finance GmbH: Preliminary Financial Results 2025: ZF Expects Operating Result and Adjusted Free Cash Flow Above Forecast Range
Published on 01/23/2026 at 10:00, 35 minutes ago Global liquidity, strong refinancing demand and rising international participation push Nordic high yield volumes to a new annual record
Published on 01/23/2026 at 09:33, 1 hour 1 minute ago PNE and EDF power solutions Deutschland commission „Gebstedt“ onshore wind farm – 16.8 MW of additional capacity for renewable energy supply
Published on 01/23/2026 at 09:00, 1 hour 34 minutes ago Original-Research: Swissnet AG (von NuWays AG): BUY
Published on 01/22/2026 at 18:00, 16 hours 34 minutes ago TERACT - Nomination de l’expert indépendant
